HALO
Halozyme Therapeutics, Inc. · Healthcare
President and CEO Helen Torley sold $1.8M of Halozyme Therapeutics, Inc.
Sold$1,773,790
$59.13Price
30,000Shares
−4%Stake
What HALO did after the filing
- The stock from Fri, Sep 13 open, $61.02
- −19.3%
- S&P 500, same days
- +3.8%
Measured over 30 trading days, to the Oct 25 close.
Traded Tue, Sep 10. Filed Thu, Sep 12, 5:56 PM ET, after the close. Returns use the Sep 13 open and the Oct 25 close. Not investment advice.